Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry
Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry | FDA
Guidance for sponsors intended to support a new drug application or a biologics license application containing recommendations for approaches can take to increase enrollment of underrepresented populations in their clinical trials.